Magenta therapeutics highlights presentations of data related to stem cell mobilization and targeted conditioning at the 2021 american society of hematology (ash) annual meeting

Cambridge, mass.--(business wire)--magenta therapeutics (nasdaq: mgta), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplants to more patients, today highlighted three presentations made at the 2021 american society of hematology (ash) annual meeting. stem cell mobilization: ash presentation and clinical development plans the data from an investigator-initiated phase 2 clinical trial in multiple myeloma, presented on dece
DNTH Ratings Summary
DNTH Quant Ranking